Results 101 to 110 of about 3,788,205 (194)

Natural Killer Cell Plasticity in Epithelial Ovarian Cancer and Their Therapeutic Implications. [PDF]

Cells
Onuma T, Asare-Werehene M, Orisaka M, Tsang BK.   +3 more
europepmc   +1 more source

Correlation between BRCA mutational status and lymph node metastasis in advanced epithelial ovarian cancer: a retrospective study. [PDF]

PeerJ
Guan M, Wang X, Ma Y, Wu Q, Zhou L, Li Y, Zhu A.   +6 more
europepmc   +1 more source

Predictive factors for long-term survivors in advanced-stage epithelial ovarian cancer. [PDF]

AJOG Glob Rep
Manchana T, Assavapokee N.
europepmc   +1 more source

Natural Compounds as Epimodulators in Epithelial Ovarian Cancer. [PDF]

Epigenomes
Lizarazo-Taborda MDR, Villegas-Pineda JC, Parada H, Galvis F, Soto J.   +4 more
europepmc   +1 more source

Clinical Value of an LDH-CA125-NLR Panel for Diagnosis, Platinum Resistance, and Prognostic Assessment in Epithelial Ovarian Cancer. [PDF]

Curr Oncol
Xu S, Guo J, Zhao Z, Zhai Y, Liu Y, Li H.   +5 more
europepmc   +1 more source

Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness. [PDF]

Oncogene
Guilbard M, Taouji S, Aubry M, Robert J, Pineau R, Velasco V, Florent R, Weiswald LB, Hartog C, Lebreton C, Coulon A, Croce S, Babin G, Chaveroux C, Beq S, Chevet E, Fessart D, Delom F.   +17 more
europepmc   +1 more source

Single-Cell Transcriptomic Analysis Reveals Ferroptosis-Related Signatures and Tumor Microenvironment Heterogeneity in Epithelial Ovarian Cancer. [PDF]

Cancer Med
Liu J, Li J, Li B, Liang H.
europepmc   +1 more source

Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study. [PDF]

Int J Womens Health
Liu X, Shen Y, Zhao Y, Gao Q, Hu T.
europepmc   +1 more source

Higher dietary phytochemical index is associated with lower risk of epithelial ovarian cancer in Chinese women: a case-control study. [PDF]

Front Nutr
Yang Y, Zhang R, Zhu M, Zu Y.
europepmc   +1 more source

IGF2BP3 promotes epithelial ovarian cancer progression by regulating FASN expression. [PDF]

Sci Rep
Sun D, Xu Y, Gao J, Cheng L, Su Y, Xu Y, He J, Lv T.   +7 more
europepmc   +1 more source